The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Open accessAbstract
BACKGROUND: The purpose of this analysis was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy. METHODS: The Prostate Cancer Outcomes Study (PCOS) enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995. The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men). Functional status was assessed at baseline and at 2, 5, and 15 years after diagnosis. We used multivariable propensity scoring to compare functional outcomes according to treatment. RESULTS: Patients undergoing prostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at 2 years (odds ratio, 6.22; 95% confidence interval [CI], 1.92 to 20.29) and 5 years (odds ratio, 5.10; 95% CI, 2.29 to 11.36). However, no significant between-group difference in the odds of urinary incontinence was noted at 15 years. Similarly, although patients undergoing prostatectomy were more likely to have erectile dysfunction at 2 years (odds ratio, 3.46; 95% CI, 1.93 to 6.17) and 5 years (odds ratio, 1.96; 95% CI, 1.05 to 3.63), no significant between-group difference was noted at 15 years. Patients undergoing prostatectomy were less likely to have bowel urgency at 2 years (odds ratio, 0.39; 95% CI, 0.22 to 0.68) and 5 years (odds ratio, 0.47; 95% CI, 0.26 to 0.84), again with no significant between-group difference in the odds of bowel urgency at 15 years. CONCLUSIONS: At 15 years, no significant relative differences in disease-specific functional outcomes were observed among men undergoing prostatectomy or radiotherapy. Nonetheless, men treated for localized prostate cancer commonly had declines in all functional domains during 15 years of follow-up. (Funded by the National Cancer Institute.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Analysis of Complex Survey Samples
Lumley, T. (2004) · Journal of Statistical Software · doi:10.18637/jss.v009.i08 · Cited by 2,425
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000) · Urology · doi:10.1016/s0090-4295(00)00858-x · Cited by 1,520 · cited 1×
“We measured disease-specific health-related quality of life using items adapted from previously validated and reliable instruments.(11-14) Multi-item rating scales were summarized as a binary measure to facilitate clinical interpretation regarding urinary incontinence, bowel function, and sexual function.”
MethodLitwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998) · Medical Care · doi:10.1097/00005650-199807000-00007 · Cited by 825
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Self-citationPatient-re ported complications and follow-up treatment after radical prostatectomy
Fowler, F. J., Barry, M. J., Lu-yao, G., Roman, A., Wasson, J., & Wennberg, J. E. (1993) · Urology · doi:10.1016/0090-4295(93)90524-e · Cited by 627
Potosky, A. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1582 · Cited by 510
Self-citation
Cited by
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Epstein, J. I., Egevad, L., Amin, M. B., Delahunt, B., Srigley, J. R., & Humphrey, P. A. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000530 · Cited by 3,236
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Cancer treatment and survivorship statistics, 2014
DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21235 · Cited by 2,779
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Epstein, J. I., Zelefsky, M. J., Sjoberg, D. D., Nelson, J. B., Egevad, L., Magi-Galluzzi, C., Vickers, A. J., Parwani, A. V., Reuter, V. E., Fine, S. W., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.046 · Cited by 1,374
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606221 · Cited by 1,338
Early Detection of Prostate Cancer: AUA Guideline
Carter, H. B., Albertsen, P. C., Barry, M. J., Etzioni, R., Freedland, S. J., Greene, K. L., Holmberg, L., Kantoff, P., Konety, B. R., Murad, M. H., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.04.119 · Cited by 1,242
Self-citationRebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
Rastinehad, A. R., Anastos, H., Wajswol, E., Winoker, J. S., Sfakianos, J. P., Doppalapudi, S. K., Carrick, M. R., Knauer, C. J., Taouli, B., Lewis, S. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906929116 · Cited by 884
Pokorny, M. R., de Rooij, M., Duncan, E., Schröder, F. H., Parkinson, R., Barentsz, J. O., & Thompson, L. C. (2014) · European Urology · doi:10.1016/j.eururo.2014.03.002 · Cited by 503
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review
Valerio, M., Ahmed, H. U., Emberton, M., Lawrentschuk, N., Lazzeri, M., Montironi, R., Nguyen, P. L., Trachtenberg, J., & Polascik, T. J. (2014) · European Urology · doi:10.1016/j.eururo.2013.05.048 · Cited by 369
Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence
Hayes, J. H., & Barry, M. J. (2014) · JAMA · doi:10.1001/jama.2014.2085 · Cited by 361
Raychaudhuri, R., Lin, D. W., & Montgomery, R. B. (2025) · JAMA · doi:10.1001/jama.2025.0228 · Cited by 355
Barocas, D. A., Alvarez, J., Resnick, M. J., Koyama, T., Hoffman, K. E., Tyson, M. D., Conwill, R., McCollum, D., Cooperberg, M. R., Goodman, M., et al. (2017) · JAMA · doi:10.1001/jama.2017.1704 · Cited by 344
Self-citationSecond malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Wallis, C. J. D., Mahar, A. L., Choo, R., Herschorn, S., Kodama, R. T., Shah, P. S., Danjoux, C., Narod, S. A., & Nam, R. K. (2016) · BMJ · doi:10.1136/bmj.i851 · Cited by 271
Grading of prostatic adenocarcinoma: current state and prognostic implications
Gordetsky, J., & Epstein, J. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0478-2 · Cited by 262
Lardas, M., Liew, M., van den Bergh, R. C., De Santis, M., Bellmunt, J., Van den Broeck, T., Cornford, P., Cumberbatch, M. G., Fossati, N., Gross, T., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.06.035 · Cited by 256
Kerns, S. L., Fachal, L., Dorling, L., Barnett, G. C., Baran, A., Peterson, D. R., Hollenberg, M., Hao, K., Narzo, A. D., Ahsen, M. E., et al. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz075 · Cited by 117
Sivarajan, G., Prabhu, V., Taksler, G. B., Laze, J., & Lepor, H. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.019 · Cited by 84
Wootten, A. C., Abbott, J.-A. M., Meyer, D., Chisholm, K., Austin, D. W., Klein, B., McCabe, M., Murphy, D. G., & Costello, A. J. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.024 · Cited by 77
Bernat, J. K., Wittman, D. A., Hawley, S. T., Hamstra, D. A., Helfand, A. M., Haggstrom, D. A., Darwish‐Yassine, M., & Skolarus, T. A. (2016) · BJU International · doi:10.1111/bju.13329 · Cited by 75
Donovan, K. A., Gonzalez, B. D., Nelson, A. M., Fishman, M. N., Zachariah, B., & Jacobsen, P. B. (2018) · Psycho-Oncology · doi:10.1002/pon.4463 · Cited by 46
Wootten, A. C., Meyer, D., Abbott, J.-A. M., Chisholm, K., Austin, D. W., Klein, B., McCabe, M., Murphy, D. G., & Costello, A. J. (2017) · Psycho-Oncology · doi:10.1002/pon.4244 · Cited by 47
The role of masculinities in psychological and emotional help seeking by men with prostate cancer
Goodwin, B. C., Ralph, N., Ireland, M. J., Hyde, M. K., Oliffe, J. L., Dunn, J., & Chambers, S. (2020) · Psycho-Oncology · doi:10.1002/pon.5264 · Cited by 32
Cormie, P., Chambers, S. K., Newton, R. U., Gardiner, R. A., Spry, N., Taaffe, D. R., Joseph, D., Hamid, M. A., Chong, P., Hughes, D., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-199 · Cited by 30
“Sexual dysfunction is one of the most common, distressing and persistent adverse effects of prostate cancer treatments [2-11] which has a profound impact on quality of life both for the patient and his partner [2-4,10,12-14].”
Lange, L., Fink, J., Bleich, C., Graefen, M., & Schulz, H. (2017) · Internet Interventions · doi:10.1016/j.invent.2017.06.001 · Cited by 22
Hypoxia‐inducible factor 1A inhibition overcomes castration resistance of prostate tumors
Terzic, J., Abu el Maaty, M. A., Lutzing, R., Vincent, A., El Bizri, R., Jung, M., Keime, C., & Metzger, D. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217209 · Cited by 21
“However, these treatments often induce side effects, such as impotence, incontinence, and infertility (Resnick et al, 2013).”
Fosså, S. D., & Dahl, A. A. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.07.004 · Cited by 19
Wittmann, D., & Koontz, B. F. (2017) · Current Sexual Health Reports · doi:10.1007/s11930-017-0095-4 · Cited by 16
Martin, S., Deng, J., Searl, T., Ohlander, S., Harrington, D. A., Stupp, S. I., Dynda, D., McVary, K. T., & Podlasek, C. A. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.04.010 · Cited by 5
Metadata
- Authors
- Resnick, M. J., Koyama, T., Fan, K.-H., Albertsen, P. C., Goodman, M., Hamilton, A. S., Hoffman, R. M., Potosky, A. L., Stanford, J. L., Stroup, A. M., Van Horn, R. L., & Penson, D. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-01-31
- Volume
- 368
- Issue
- 5
- Pages
- 436-445
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1968400906
- Cited by
- 979
- References
- 31
- FWCI
- 87.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.